Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-613-0 | CAS number: 97-86-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Reference Type:
- other: Thesis
- Title:
- Unnamed
- Year:
- 2 002
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 428 (Skin Absorption: In Vitro Method)
- GLP compliance:
- no
Test material
- Reference substance name:
- Isobutyl methacrylate
- EC Number:
- 202-613-0
- EC Name:
- Isobutyl methacrylate
- Cas Number:
- 97-86-9
- Molecular formula:
- C8H14O2
- IUPAC Name:
- isobutyl methacrylate
- Details on test material:
- Methacrylic acid from Ineos Acrylics (Lot 98/42; purity > 99%), methyl methacrylate from Ineos Acrylics (Lot 98/15; purity > 99%), ethyl methacrylat from Atofina (Lot 011666; purity: > 99%), i-butyl methacrylate from Ineos Acrylics (Lot 98/15; purity 99%), n-butyl methacrylate from Ineos Acrylics (Lot 98/15; purity 99%), hexyl methacrylate from Röhm GmbH (Lot 78070243; purity > 98%), 2-ethylhexyl methacrylate from Röhm GmbH (Lot 78080370; purity > 98%), octyl methacrylate from Röhm GmbH (Lot 22-902-13914-28; purity > 98%)
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
Administration / exposure
- Type of coverage:
- open
- Vehicle:
- unchanged (no vehicle)
- Duration of exposure:
- 48 hours
- Doses:
- 100 µl/cm²
- Details on in vitro test system (if applicable):
- The absorption of iBMA was evaluated through rat and human epidermis and through rat whole skin in an in vitro system.
Results and discussion
- Signs and symptoms of toxicity:
- not examined
- Dermal irritation:
- not examined
- Absorption in different matrices:
- The properties of i-BMA were determined by statistical analysis (single exponential fit). The original data were obtained with other members of the lower alkyl methacrylate category (MAA, MMA, n-BMA, 2-EHMA and n-octyl methacrylate).
Absorption of i-BMA through rat epidermis:
The fastest rate of absorption (mean) of nBMA through rat epidermis was estimated to be 1418 µg cm-2 hr-1.
Absorption of i-BMA through human epidermis:
The rate of absorption of isobutyl methacrylate was estimated to be 80 µg cm-2 hr-1. For n-BMA, the closest analogue measured, just over 2% of the applied dose was absorbed over the exposure period.
Absorption of i-BMA through whole (viable) rat skin
Only methacrylic acid (MAA) appeared in the receptor chambers of skin that had had n-butyl methacrylate applied to the surface. The same would be expected for i-BMA because of the close structural analogy. This would imply that all of the i-BMA that is absorbed through the skin is hydrolysed by carboxylesterases that are present in this tissue. The peak rate of appearance of MAA was estimated to be 56 µg cm-2 hr-1. For n-BMA the experiment did not extend beyond ten hours, and the percentage dose removed from the donor reservoir was 0.4%.
Percutaneous absorptionopen allclose all
- Dose:
- 100 µl/cm²
- Parameter:
- percentage
- Absorption:
- ca. 18 %
- Remarks on result:
- other: 24 hours
- Remarks:
- Rat epidermis, measured with n-BMA
- Dose:
- 100 µl/cm²
- Parameter:
- percentage
- Absorption:
- 2 %
- Remarks on result:
- other: 24 hours
- Remarks:
- Human epidermis, measured with n-BMA
- Dose:
- 100 µl/cm²
- Parameter:
- percentage
- Absorption:
- 0.4 %
- Remarks on result:
- other: 10 hours
- Remarks:
- Whole (viable) rat skin, measured with n-BMA
- Conversion factor human vs. animal skin:
- Human epidermis appears to be 20 times less permeable to nBMA than rat epidermis.
Any other information on results incl. tables
The results of the whole-skin penetration studies and the model predictions for
other
methacrylate esters are presented
in the table.
Table: Summary of peak rates of absorption of MAA and alkyl-methacrylate
esters
through whole rat skin.
Table: Summary of the results for the peak rates of absorption of MAA & alkylmethacrylate esters through rat & human epidermis
|
Rat epidermis |
Human epidermis |
|||||||
Ester |
Peak rate of absorption (μg cm-2hr-1) ±SEM |
Period of peak absorption rate (hours) |
% age of applied dose absorbed over x hours |
Peak rate of absorption (μg cm-2hr-1) ±SEM |
Period of peak absorption rate (hours) |
% age of applied dose absorbed over x hours |
|||
MAA |
23825±2839 |
0.5-4 |
93% / 24h |
812 |
- |
- |
|||
MMA |
5888±223 |
2-8 |
46% / 16h |
453±44.5 |
4-24 |
10% / 24h |
|||
EMA |
4421 |
- |
- |
253 |
- |
- |
|||
i-BMA |
1418 |
- |
- |
80 |
- |
- |
|||
n-BMA |
1540±69 |
0-6 |
18% / 24h |
76.7±9.8 |
0-24 |
2% / 24h |
|||
HMA |
147 |
- |
- |
25 |
- |
- |
|||
2EHMA |
234±4.8 |
0-30 |
7.8% / 30h |
22.7.7±3.7 |
3-24 |
0.6% / 24h |
|||
OMA |
159±15 |
0-24 |
- |
7.8 |
- |
- |
Ester Peak = rate of appearance of the parent ester (µg/cm2/hr)
MAA
Peak = rate of appearance of the hydrolysis product, MAA (µg/cm2/hr)
Period Peak Absorp. = Time (hours) after application for peak absorption
% Applied Dose = total % absorbed
** Predicted rates of MAA from model estimates.
Applicant's summary and conclusion
- Conclusions:
- i-BMA readily absorbs through rat and human epidermis and through whole rat skin. Human epidermis appears to be approx. 20 times less permeable to i-BMA than rat epidermis.
- Executive summary:
The properties of i-BMA were determined by statistical analysis (single exponential fit). The original data were obtained with other members of the lower alkyl methacrylate category (MAA, MMA, n-BMA, 2-EHMA and n-octyl methacrylate).
The absorption of i-BMA was estimated for rat and human epidermis and through whole (viable) rat skin in an in vitro system. Glass diffusion cells were employed to measure the amount of substance that is received into a receptor chamber with respect to time, following the application of 100 µl/cm² of the respective substance to the epidermal surface. The calculated mean rate of absorption was 1418, 80 and 56 (appearance of MAA) µg cm-2 hr-1 and the total amount of chemical that was absorbed during the time of exposure was 18 (for the closest analogue n-BMA over 24 hours), 2 (n-BMA over 24 hours) and 0.4% (n-BMA over 10 hours), respectively. I-BMA appears to be readily absorbed through rat and human epidermis, but human epideremis is 20 times less permeable to i-BMA than rat epidermis.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.